Mazzocchi salary income and net worth data provided by people ai provides an estimation for any internet celebritys real salary income and net worth like rudy a. Mazzocchi founded and sold several companies in the medical space including microvena, vascular science, inc. As recently described in an interview on biotuesdays, elenza combines nanotechnology, artificial intelligence neural networksbased memory, and advanced. Xtant medical announces changes to its executive management and board of directors belgrade, mont. Amitava gupta, along with ceo rudy mazzocchi, designed a revolutionary accommodative iol sometimes also. Actuating the device causes the fluidfilled membrane to change.
Use the pitchbook platform to explore the full profile. The companys filing status is listed as 00 active and its file number is f175387. Rudy mazzocchi is 61 years old today because rudy s birthday is on 12051958. In 2010, elenza was on the verge of solving that problem. Rudy s incredibly impressive medtech career includes obtaining more than 50 patents, as well as founding or cofounding 11 companies across several medical specialties including cardiology, oncology, orthopedics, neurosurgery, and embryonic. Fluor early career chair of engineering and associate professor of chemical engineering and materials science. Intraocular lens to compete in the multibillion dollar iol market. Clare boothe luce postdoctoral fellow at the california institute of technology in biology under. In his current ceo role at elenza, rudy mazzocchi has once again strived to overcome the challenges in todays economy to finance and build another medtech company from the ground up. Rudy mazzocchi isnt your average serial entrepreneur. Other names that rudy uses includes r amplatz, raphael mazzocchi, ralph a mazzocchi, rudy anthony mazzocchi and rudy a mazzocchi.
This listing includes patent applications that are pending as well as patents that have already been granted by the united states patent and trademark office uspto. An implantable ophthalmic device with flexible, fluidfilled membranes provide dynamically variable optical power to restore lost accommodation in individuals suffering from presbyopia or aphakia without moving parts or reducing the amount of transmitted light. Mazzocchi s profile on linkedin, the worlds largest professional community. Rudy mazzocchi has filed for patents to protect the following inventions. The emergence of biomarkers linking disease and treatment effects in a clear manner presents an opportunity to change the current drug development paradigm, which could lead to more costefficient and higherquality clinical trials. Serving as chief executive officer of elenza, rudy mazzocchi has once again strived to overcome the challenges in todays economy to finance and build another medtech. Rudy mazzocchi has served in a parttime capacity as establishment labss president since october 2015 on board of directors as executive chairman since september 2015.
Justia patents patents and patent application resources. Attendees as of november 5th, 2012 ophthalmology innovation. His voice elevates with excitement when speaking of the iol, calling it the type of innovation that comes along once in a lifetime. Aerie pharmaceuticals provides 2020 company and guidance update associated with covid19. Our products follow this logic and cater to the individual.
Rudy anthony mazzocchi was born in pittsburgh, pennsylvania where he attended the university of pittsburgh as a premed student and then went on to graduate studies at ucla where he worked in the first human genetic engineering lab. Rudy mazzocchi is chief executive officer of elenza roanoke, va. Rudy mazzocchi joins the greatbatch board of directors as. Elenza develops an accommodative iol to address the limitations of standard iols. The wisdom behind the strategies that have driven elenza s success, from not rushing new products to market to. Despite having no formal business training, mazzocchi has managed to parlay a background in biochemistry and biophysics into a successful business career that has launched a bevy of thriving startups acquired by. Rudy mazzocchi inventions, patents and patent applications. Juggling the demands of his dayjob as chief executive officer of elenza, a developmentstage ophthalmology device company, rudy mazzocchi has somehow managed to.
Products should be designed because of people, not in spite of people. Rudy s incredibly impressive medtech career includes obtaining more than 50 patents, as well as founding or cofounding 11 companies across several medical specialties including cardiology, oncology, orthopedics, neurosurgery, and embryonic stemcell development. Materials selection and iso 10993 biocompatibility update. More than 150 patents and patent applications have been filed. Elenza developed the electronic autofocal intraocular lens, giving patients clear and natural visibility over the full range of vision. Founded in march of 20, laforge optical is a company that designs and markets eyewear with an embedded headsup display system. Awardwinning novelist and medtech executive prepares for. Elenzas highly proprietary next generation accommodating iol is designed to give patients a complete visual range, providing effective near. That is exactly what serial entrepreneur rudy mazzocchi has with the earlystage company elenza, which mazzocchi says is presently considering acquisition opportunities. Since taking over as ceo of elenza, mazzocchi has launched some 50 patents and founded a spate of startups across a wide swath of industries, from oncology to neurosurgery to cardiology. Mazzocchi has 27 years of senior management and financing experience in the medical technology industry and has extensive healthcare background includes an academic, management and venture perspective. Elenza is targeting the 25 million cataract operations that occur each year in the world, as well as the 100 million pairs of multifocal eyewear that are sold each year worldwide. Rudy mazzocchi has over 25 years of senior management, technology development and financing experience in the medical devices industry. He is currently the ceo of elenza, executive chairman of establishment labs.
The following 2 pages are in this category, out of 2 total. Elenza s headquarters is located in roanoke, virginia, usa 24019. Newsletter march 2016 regenerative medicine at the mcgowan. Aerie pharmaceuticals competitors, revenue and employees. Creating an autofocusing intraocular lens mddi online. Mazzocchi to its board of directors originally appeared on. Jane lebkowski, president regenerative patch technologies. Mazzocchi has been elected to its board of directors. See the complete profile on linkedin and discover rudy a. Before moving to rudy s current city of indian harbour beach, fl, rudy lived in satellite beach fl and rockledge fl.
The stink of having the market leader walk away from their investment commitment, for no. It is also our privilege to recognize the leadership of rudy mazzocchi as. Wells student health care entrepreneurship competition winner 4 p. This will probably be the biggest thing ill ever do, he said. Mazzocchi will then end with an animated description of his next novel, equity of fear, anticipated for release in february of 20. Elenza s ceo stated, ive reached out to 63 venture funds over the past 18 months, and the most prevalent reason for passing was because we do not yet have clinical data or revenues. The primary aim is to educate and update rehabilitation and. The registered agent on file for this company is ct corporation system and is located at 4701 cox road, suite 285, glen allen, va 230600000.
He is currently the ceo of elenza, executive chairman of establishment labs holdings, inc. View rudy mazzocchi s business profile as chief executive officer at elenza, inc find contacts direct phone number, email address, work history, and more. Elenza was an ophthalmic company that sought to develop an electroactive intraocular lens eaiol. Virginia company alleges alcon stole trade secrets on lens. Rudy is best known as a medical device and biotechnology entrepreneur, inventor and angel investor whom has a. Alcon laboratories holding corporation alcon develops and markets standard cataract replacement lenses, called intraocular lenses iol. He has decades of senior management and financing experience in the medical technology industry and has founded and led five. Mazzocchis profile on linkedin, the worlds largest professional community. Elenza involves in developing the electronic auto focal intraocular lens to iol market. He serves currently as cofounderchief executive officer of elenza, inc, an ophthalmology company that has developed an electroactive, autofocusing, implantable lens. How elenza got to this device, with plans for ce mark approval within 18 to 22 months, is a great example of how advanced electronics are spurring innovation. Medical device veteran and author, rudy mazzocchi is.
And there is certainly no disputing the incredible success of medical device entrepreneur and investor rudy mazzocchi, who is currently the ceo of elenza. Newsletter update norris needs everything as soon as possible so he can publish next week. Information on acquisition, funding, investors, and executives for elenza. This trait is rare in a world full of outsidethebox thinkers who typically rely on others to a raise the capital and b build the processes necessary to execute upon the novel strategiesconcepts.
It is also our privilege to recognize the leadership of rudy mazzocchi as president and chief executive officer of elenza, an experienced medical device entrepreneur who was recruited to. Indicate by check mark whether the registrant is a shell company as defined in rule 12b2 of the exchange act. Rudy mazzocchi is best known as a medical device and biotechnology entrepreneur, inventor, and angel investor, with a history of starting new. Rudy is best known as a medical device and biotechnology entrepreneur, inventor, and angel investor, with a history of starting new technology ventures throughout the u. Rudy mazzocchi anthony, 61 indian harbour beach, fl. Xtnt, a leader in the development of regenerative medicine products and medical devices, today announced the appointment of paul buckman, eric timko, and rudy mazzocchi to. Medical device veteran and author, rudy mazzocchi is honored as one of top 50 innovators at the 20 venture summit conference share article as chief executive officer of elenza, inc.
693 656 1457 858 790 1076 1290 254 921 246 1091 1335 1098 597 537 944 356 176 79 384 1313 1411 336 216 421 982 1035 743 880 644 1329 360 581 383 1164 1053 1291 509 1394 237 599 1287 780 363 541 1220 1371 457